Table 3 Combination antifungal therapy during period of hospitalization
From: A case series of medically managed Candida parapsilosis complex prosthetic valve endocarditis
Admission time | Hospital stays | Antifungal drugs | Period | Administration | Antifungal drugs | Period | Administration | Antifungaldrugs | Period | Administration | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Case 1 | 2017/12/24 | 12 days | Voriconazole | 12–25 to 12–28 | 200 mg IV Q12H | Caspofungin | 12–28 to 1–8(2018) | 50 mg Q12H iv | / | / | / |
Case 2 | 2019/11/4 | 31 days | Voriconazolerr | 11–4 to 11–21 | 200 mg IV Q12H | Caspofungin | 11–21 to 12–4 | 50 mg Q12H iv | Amphotericin B | 11–26 to 12–4 | 1 mg IV QD |
Case 3 | 2015/11/22 | 14 days | Fluconazole | 11–23 to 11–27 | 100 ml IV QD | Voriconazole | 11–27 to 12–4 | 200 mg IV Q12H | / | / | / |
Case 4 | 2019/11/7 | 4 days | Fluconazole | 11–7 to 11–9 | 100 ml IV QD | Caspofungin | 11–9 to 11–10 | 50 mg QD iv | / | / | / |